EUVIMEDEUVIMED entdecken
Crossref

Integrated Experimental and Molecular Modeling Techniques to Investigate the Buffer Effects on Glucagon Stability

Zi-Ting Xu, Bogang Li, Jiayin Deng, Jia-Yi Lv, Defang Ouyang, Wei-Jie Fang

Pharmaceutical Research · 2026-03 · 43 (3) · 859-875

DOI: 10.1007/s11095-026-04022-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Research, online erschienen am 06.03.2026. Verfasst von Zi-Ting Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. Hauptthemen laut MEDLINE: Glucagon. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Municipal-University Cooperation Projects of Taizhou Institute of Zhejiang University, Taizhou Science and Technology Plan Projects, Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSES: Peptide drugs are a vital category of biologics. However, unlike the well-studied effects of buffers on small-molecule or macromolecule drugs, the understanding of selecting appropriate buffers for peptide formulations and their specific impacts remains insufficient. This study aimed to systematically evaluate how different buffers affect the stability of the model peptide, glucagon, and to investigate the underlying mechanisms at the molecular level. METHODS: This work employed glucagon as a model peptide and integrated experimental techniques with computational approaches. Experimental techniques included reverse-phase high-performance liquid chromatography (RP-HPLC), Thioflavin T fluorescence assays, and circular dichroism (CD). Molecular dynamics (MD) simulations were further conducted, utilizing models with different buffer systems and varying peptide counts, to examine the interaction mechanisms between buffers and glucagon from multiple perspectives. RESULTS: Compared with other buffers, citrate exerted a unique and significant impact on glucagon stability. RP-HPLC demonstrated its destabilizing effect on the structure, while CD and MD simulations confirmed its role in preserving glucagon's α-helical structure, attributed to its highest binding energy. However, this strong binding reduced the ζ-potential, compromised colloidal stability, and ultimately promoted aggregation/precipitation. MD simulations further showed that citrate anions formed a denser solvation shell around glucagon, driving oligomerization and aggregation. CONCLUSIONS: This work uncovers the dual role of citrate buffer on glucagon stability: maintaining local secondary structure while disrupting overall colloidal stability. It provides molecular insights into peptide-excipient interactions and offers valuable guidance for optimizing formulations for other peptide drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucagonMolecular Dynamics SimulationBuffersCircular DichroismProtein StabilityChromatography, High Pressure LiquidDrug StabilityChromatography, Reverse-PhaseProtein Structure, SecondaryBenzothiazoles

Stichwörter der Autor:innen

BufferCitrateGlucagonMolecular dynamicsPeptide aggregationPeptide stability

Substanzen

GlucagonBuffersBenzothiazoles

Autor:innen und Institutionen

  • Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
  • Taizhou Institute of Zhejiang University, Taizhou, 318000, China.
  • The State Key Laboratory of Mechanism and Quality of Chinese Medicine (University of Macau), Institute of Chinese Medical Sciences (ICMS), University of Macau, Macau, China.
  • The State Key Laboratory of Mechanism and Quality of Chinese Medicine (University of Macau), Institute of Chinese Medical Sciences (ICMS), University of Macau, Macau, China. defangouyang@um.edu.mo.
  • Department of Public Health and Medicinal Administration, Faculty of Health Sciences (FHS), University of Macau, Macau, China. defangouyang@um.edu.mo.
  • Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. wjfang@zju.edu.cn.

Förderung

  • Municipal-University Cooperation Projects of Taizhou Institute of Zhejiang University
  • Taizhou Science and Technology Plan Projects
  • Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China
  • Jinhua Science and Technology Plan Projects
  • University of Macau Multi-Year Research Grant

Zitieren

APA

Xu, Z. T., Li, B., Deng, J., Lv, J. Y., Ouyang, D., & Fang, W. J. (2026). Integrated Experimental and Molecular Modeling Techniques to Investigate the Buffer Effects on Glucagon Stability. Pharmaceutical Research, 43(3), 859-875. https://doi.org/10.1007/s11095-026-04022-6

Vancouver

Xu ZT, Li B, Deng J, Lv JY, Ouyang D, Fang WJ. Integrated Experimental and Molecular Modeling Techniques to Investigate the Buffer Effects on Glucagon Stability. Pharmaceutical Research. 2026;43(3):859-875. doi:10.1007/s11095-026-04022-6

BibTeX
@article{Xu2026,
  author = {Xu, Zi-Ting and Li, Bogang and Deng, Jiayin and Lv, Jia-Yi and Ouyang, Defang and Fang, Wei-Jie},
  title = {Integrated Experimental and Molecular Modeling Techniques to Investigate the Buffer Effects on Glucagon Stability},
  journal = {Pharmaceutical Research},
  year = {2026},
  volume = {43},
  number = {3},
  pages = {859--875},
  doi = {10.1007/s11095-026-04022-6}
}
Kostenlos starten →